Literature DB >> 2228158

Pressor systems in hypertension and congestive heart failure. Role of vasopressin.

H Gavras1.   

Abstract

Elevated peripheral vascular resistance, which characterizes hypertension and congestive heart failure (the latter regardless of absolute blood pressure level) is maintained to a large extent by the combined effects of three major neurohormonal pressor mechanisms: the renin-angiotensin system, the sympathoadrenal system, and arginine vasopressin. Blockade of one of these mechanisms may lead to compensatory stimulation of the others, thus offsetting in part the hemodynamic benefits of a specific intervention. Combination therapy, designed to attack all three systems (with use of an angiotensin converting enzyme inhibitor, a sympathetic blocker such as clonidine, and an antagonist of the vasopressor action of vasopressin), may help in the treatment of such cases. To illustrate this strategy, two experimental studies, one case of malignant hypertension, and one case of congestive heart failure are presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228158     DOI: 10.1161/01.hyp.16.5.587

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Exacerbated effects of prorenin on hypothalamic magnocellular neuronal activity and vasopressin plasma levels during salt-sensitive hypertension.

Authors:  Soledad Pitra; Caleb J Worker; Yumei Feng; Javier E Stern
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-07-05       Impact factor: 4.733

2.  Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent.

Authors:  Nicole K Littlejohn; Rick B Siel; Pimonrat Ketsawatsomkron; Christopher J Pelham; Nicole A Pearson; Aline M Hilzendeger; Beth A Buehrer; Benjamin J Weidemann; Huiping Li; Deborah R Davis; Anthony P Thompson; Xuebo Liu; Martin D Cassell; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

3.  Oxytocin receptors expressed and coupled to Ca2+ signalling in a human vascular smooth muscle cell line.

Authors:  H Yazawa; A Hirasawa; K Horie; Y Saita; E Iida; K Honda; G Tsujimoto
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model.

Authors:  Mark K Santillan; Donna A Santillan; Sabrina M Scroggins; James Y Min; Jeremy A Sandgren; Nicole A Pearson; Kimberly K Leslie; Stephen K Hunter; Gideon K D Zamba; Katherine N Gibson-Corley; Justin L Grobe
Journal:  Hypertension       Date:  2014-07-07       Impact factor: 10.190

5.  Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT?

Authors:  Irene Gavras; Haralambos Gavras
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

6.  Serum copeptin levels in adolescents with primary hypertension.

Authors:  Edyta Tenderenda-Banasiuk; Anna Wasilewska; Renata Filonowicz; Urszula Jakubowska; Marlena Waszkiewicz-Stojda
Journal:  Pediatr Nephrol       Date:  2013-12-29       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.